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High-Resolution melting curve analysis (HRM) is a rapid, high-throughput, closed-
tube method for mutation scanning and genotyping. Here we present evaluation
of HRM for mutation scanning applied to the analysis of the cystic ﬁbrosis trans-
membrane conductance regulator (CFTR) gene. Thirty four test samples derived
from CF patients with a known CFTR genotype, determined by direct sequencing
(ABI3130 genescanner, BigDye terminator chemistry), were selected for testing of
the sensitivity, speciﬁcity and repeatability of HRM. We scanned 19 different disease
causing CFTR mutant genotypes located within 6 exons of the CFTR gene (4, 7, 10,
11, 14b, 22) and compared them with sequencing-veriﬁed wild-type samples. These
mutations comprised F508del, I507del, G551D, R347P, 1717−1G>A, 621+1G>T,
Y122X, I336K, R553X, 2789+5G>A, 574delA, 1811+1G>C, L1335F, L1335P,
L1324P and represent minimally 76.5% of all CF alleles detected in the Czech CF
population. Ampliﬁcation and melting curve analysis was performed on Corbett Life
Science RotorGene 6000 (Corbett Research, Australia) using the ﬂuorescent double-
strand DNA intercalating dye LCGreen plus (Idaho Technology, Utah, USA). All
analysed samples with mutant genotypes were unambiguously distinguished from
wild-type sequences. In conclusion, HRM analysis enables reliable detection of all
SNP classes and 1- or 3-base-pair deletions and has a high utility for the detection
of unknown mutations in CF DNA diagnostics.
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Mutational analysis of the CFTR gene is crucial for CF diagnosis, prognosis, therapy
and prevention. A rapid approach is needed that, by using a widespread automated
instrumental platform, would combine low cost and high detection rate. In previous
work we established a multiplexed minisequencing test (CF-SNAP+20, based on
the SNaPshot kit, Applied Biosystems) for the search of a regional-speciﬁc panel
of 14 CFTR mutations, additional to those of the CF-OLA assay (Abbott), and also
a procedure for extensive re-sequencing of CFTR.
We are presenting here the automation of both procedures by a Hamilton MicroLab
StarLet robotics system and an Applied Biosystems ABI PRISM 3100 genetic
analyzer, as well as the results of a pilot study performed on 335 CF subjects
of Central Italy. The automated CF-SNAP+20 led to a 2-days test at a cost of
€ 15/subject; the detection rate reached by its combination with the CF-OLA was
88%. The CFTR extensive re-sequencing was (on a 16-channels analytical platform)
a 5 days-test at a cost of € 250/subject, with a detection rate of 96%.
By enhancing the CF-SNAP mutational panel (also as a substitution for the CF-
OLA) and by using a ﬂuorescent PCR test for the detection of the most common
CFTR deletions (at an overall cost of € 35/subject), this methodology becomes
particularly suitable also for carrier screening in the general population. Residual
risk for negative couples is less than 1:200,000, limiting the need of the extensive
re-sequencing step to the negative partner of intermediate risk couples.
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18 years after the discovery of the CFTR gene, more than 1500 anomalies were
described in the world, the majority of them being single base-pair substitutions
or micro-insertions/deletions. Identiﬁcation of mutations has important implications
for genetic counselling, prenatal diagnosis, cascade screening in families, as well
as for understanding the genotype-phenotype relationship.
High resolution melting analysis is a new single tube gene scanning technique based
on the difference in melting behaviour between homoduplexes and heteroduplexes
saturated with a double-strand DNA speciﬁc ﬂuorochrome, the LC-Green. We have
applied and validated this technique for detection of mutations in the CFTR gene
30 pairs of primers were designed and modiﬁed with addition of a short GC-
clamp, depending on the melting curves domains of the fragments, in order to
obtain one single melting domain, and to amplify under the same conditions the
27 exons of the gene and the exon-intron junctions. Ampliﬁcations were done with
a single amplicon by exon, except for exons 17b and 13 which were respectively
split in 2 and 4 fragments. Samples were imaged in a 96-well Lightscanner (Idaho
Technology). Analysis conditions for the CFTR gene were validated with wild-
type samples and more than 200 DNA carrying known variants (mutations and
polymorphisms) previously identiﬁed by DHPLC and sequencing.
In our conditions, scanning identiﬁed all heterozygous variants, and most of the
samples containing frequent polymorphisms had a particular proﬁle and were
distinguishable from another carrying a different mutation.
In conclusion, this single tube technique is simple, fast, effective, and economical
and can be automated for use in routine scanning of the CFTR gene.
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Recently, large rearrangements in the CFTR gene have been detected in a broad
variety of populations accounting for ~2% of all mutated genes in patients with
classical forms of the disease or CBAVD. In some populations their frequency
increases up to 5% of all CF chromosomes, as e.g. CFTRdele2,3(21kb) in Slavic
populations. Standard PCR-based methods can only provide indirect hints of their
presence when haplotypes and/or linkage do not ﬁt expected segregation patterns
due to rearrangement-associated hemizygosity. Multiplex Ligation-Dependent Probe
Ampliﬁcation (MLPA) is one of the methods which allows for identiﬁcation of
large deletions/duplications in the CFTR gene. However, since MLPA is based
on relative quantiﬁcation of a copy number of PCR-multiplexed speciﬁc sequences,
suitable computerized analysis of raw data is very important for proper interpretation
of quantitative read-outs. There are commercial, proprietary and freely distributed
software applications which have a various degree of user friendliness, diagnostic
utility, sensitivity and speciﬁcity. Moreover, usually these are not web based and do
not allow for optimization of utilized algorithms by long-term “feedback learning”
from centrally stored data pools for given sequences of interest. Consequently, we
have developed the “eMLPA” web based application that is a universal interface for
MLPA assays. It provides uniform and well-arranged processing of measured data,
choice of normalization, including the analysis itself. One of the advantages of our
software is the possibility to store data for statistics or data quality control.
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